T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
about
Gadolinium-based contrast agent toxicity: a review of known and proposed mechanismsGadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.T1 hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition?Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissuesQuantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.Gadolinium-based contrast agents: did we miss something in the last 25 years?Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model.Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.Gadolinium retention in the body: what we know and what we can do.Blood-Brain Barrier Permeability and Gadolinium: Benefits and Potential Pitfalls in Research.Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats.Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats.Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update.Cumulative Dose of Macrocyclic Gadolinium-Based Contrast Agent Improves Detection of Enhancing Lesions in Patients with Multiple Sclerosis.Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study.Repeated intravenous administration of gadobutrol does not lead to increased signal intensity on unenhanced T1-weighted images-a voxel-based whole brain analysis.Gadolinium-based contrast agents: A comprehensive risk assessment.Imaging Markers for Monitoring Disease Activity in Multiple Sclerosis.Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients.Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study.Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue.T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosisBiological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus.Deep Brain Nuclei T1 Shortening after Gadobenate Dimeglumine in Children: Influence of Radiation and Chemotherapy.Gadolinium Accumulation in the Deep Cerebellar Nuclei and Globus Pallidus After Exposure to Linear but Not Macrocyclic Gadolinium-Based Contrast Agents in a Retrospective Pig Study With High Similarity to Clinical Conditions.Absence of clinical cerebellar syndrome after serial injections of more than 20 doses of gadoterate, a macrocyclic GBCA: a monocenter retrospective study.The Effects of Gadolinium-Based Contrast Agents on the Cerebellum: from Basic Research to Neurological Practice and from Pregnancy to Adulthood.Intravoxel incoherent motion MRI as a means to measure in vivo perfusion: A review of the evidence.Recent Advances in Understanding Gadolinium Retention in the Brain.Distribution and chemical forms of gadolinium in the brain: a review.Cerebral blood flow, transit time, and apparent diffusion coefficient in moyamoya disease before and after acetazolamide.Use of gadolinium-based magnetic resonance imaging contrast agents and awareness of brain gadolinium deposition among pediatric providers in North America.Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.T1 hyperintensity in the brain after multiple intravenous injections of gadolinium-based contrast agents.Reply to Letter to the Editor re: Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: Correlation with cumulative dose of a mChiral DOTA chelators as an improved platform for biomedical imaging and therapy applications.
P2860
Q26751073-F838C230-3E78-4832-8C2C-6136BBF37E48Q31045014-D4CD6EE6-5934-4432-9660-BC01683241FEQ31132207-42C325A2-5BBF-4AA1-9B3A-8A97452DA060Q33613096-ED6FC3FE-FC78-45AD-B50D-B3FEB97BA96CQ33778968-B786354E-9DAF-48C8-B47E-E5ED9B0CA5A9Q35878856-1242480B-7413-40E3-B7AA-2E3B9B772A19Q36085936-049876CC-956B-4B9C-90A0-C815F1E74030Q36316226-19428807-9CE0-4B49-882A-114ADAB25E14Q36329191-9A688B39-95A2-4250-90C5-E1194900B027Q36531442-046E2EDB-B545-46C7-8843-02607AF4D311Q36564222-5737B0A4-E483-4D93-8025-B813B5A16F10Q37605738-FEF6E315-90C6-49F5-8337-FE28B28ADB52Q37740128-49418ECE-0121-4746-85D7-6EFBE14AD75AQ38327912-C9F2A394-A034-4262-8624-229D882B4B4DQ38667169-3E743CF2-775E-4462-9E2D-4C082AD95101Q38723319-74538E91-AE76-4194-81EC-1113C3890E9CQ38790916-313CADB9-82AD-4DDE-A31C-14148FA0BCB6Q38910017-41884D9D-9FC6-4C5B-B861-F585AEDCA687Q39022872-FAD5E688-4781-4101-B7D1-06A64CCF9043Q39247449-DAF81BBC-69E4-4B50-9345-0EE8A2EB1399Q40062884-37C240AA-7E36-48D1-BB89-400846F1216EQ40267502-12CB98F1-8D15-43F1-B8FA-248AB18C95F0Q41029307-3E9CE684-1C40-4D67-BF3D-214E5ED0F049Q41349195-132B4DD9-EFC0-41C9-9562-ECFFE5CB77D7Q46158473-A297D87E-E042-48D7-8077-D5F0E55A946CQ47340326-EE10BA49-4A89-4397-AF17-CDBE9842C032Q47872616-85596714-B5BE-4176-BA6D-E58E021FC5E6Q47909842-70C82D83-D20F-4029-AFEC-F6F9C920E0A0Q47939060-2E8B5712-993D-4CD8-BD5A-F9199219FF7AQ48103389-0538DBEF-C08E-496C-A799-10C459186EE8Q48115344-3EEE8E2D-6F48-4CBD-8CB2-6B76BF5D2218Q48177361-149F85C8-75F6-44A3-9155-1DCF8F08D55AQ48182210-10D5EF66-058D-41BC-B45A-7BA40F56E0A7Q48268779-151C6B8E-1BAC-49FD-8FF5-C1793789E044Q48359444-853CD255-03B4-4145-9D4F-F40418F2D7E9Q48493942-7D2A5B2B-F0F3-4F0D-8D67-29AB4ED6077AQ48881071-63A21387-0EFF-4BFD-9834-1DE2C9024C13Q48959521-CB8ED4D1-C03A-4D99-A4A0-476A77FDFFF6Q52148996-5573D84F-7651-4A1A-A958-8B118193DD97Q52682401-619434CC-1BFC-430C-B3CF-34FEB598C559
P2860
T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
T1-Weighted Hypersignal in the ...... Linear and Macrocyclic Agents.
@ast
T1-Weighted Hypersignal in the ...... Linear and Macrocyclic Agents.
@en
type
label
T1-Weighted Hypersignal in the ...... Linear and Macrocyclic Agents.
@ast
T1-Weighted Hypersignal in the ...... Linear and Macrocyclic Agents.
@en
prefLabel
T1-Weighted Hypersignal in the ...... Linear and Macrocyclic Agents.
@ast
T1-Weighted Hypersignal in the ...... Linear and Macrocyclic Agents.
@en
P2093
P2860
P1476
T1-Weighted Hypersignal in the ...... Linear and Macrocyclic Agents.
@en
P2093
Claire Corot
Jean-Marc Idée
Nathalie Fretellier
Philippe Robert
Stéphane Lehericy
Sylvie Grand
Sébastien Ballet
Xavier Violas
P2860
P304
P356
10.1097/RLI.0000000000000181
P577
2015-08-01T00:00:00Z